Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Gabriel C Quintero Garzola. (2020) The Use of Gabapentin for the Treatment of Alcohol and Tobacco Use Disorders: A Review. Open Access Journal of Clinical Trials 12, pages 43-60.
Read now
Read now
Michael Soyka & Christian A. Müller. (2017) Pharmacotherapy of alcoholism – an update on approved and off-label medications. Expert Opinion on Pharmacotherapy 18:12, pages 1187-1199.
Read now
Read now
Michael Soyka, Henry R. Kranzler, Victor Hesselbrock, Siegfried Kasper, Jochen Mutschler & Hans-Jürgen Möller. (2017) Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision. The World Journal of Biological Psychiatry 18:2, pages 86-119.
Read now
Read now
Michael Soyka. (2016) Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential. Expert Opinion on Pharmacotherapy 17:4, pages 619-626.
Read now
Read now
Jonathan Tomas Lockwood & Gary Remington. (2015) Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials. Expert Opinion on Emerging Drugs 20:3, pages 407-421.
Read now
Read now
Articles from other publishers (49)
Stefan Gutwinski & Andreas Heinz. 2023. Psychoneuroscience. Psychoneuroscience
243
261
.
Josephin Wagner, Andrew S. Bell, Jeesun Jung & Falk W. Lohoff. 2023. Alcohol and Alcohol-related Diseases. Alcohol and Alcohol-related Diseases
595
621
.
Pascal Valentin Fischler, Michael Soyka, Erich Seifritz & Jochen Mutschler. (2022) Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review. Frontiers in Pharmacology 13.
Crossref
Crossref
Falk W. Lohoff. (2022) Targeting Unmet Clinical Needs in the Treatment of Alcohol Use Disorder. Frontiers in Psychiatry 13.
Crossref
Crossref
Aurélia Gay, Julien Cabe, Ingrid De Chazeron, Céline Lambert, Maxime Defour, Vikesh Bhoowabul, Thomas Charpeaud, Aurore Tremey, Pierre-Michel Llorca, Bruno Pereira & Georges Brousse. (2022) Repetitive Transcranial Magnetic Stimulation (rTMS) as a Promising Treatment for Craving in Stimulant Drugs and Behavioral Addiction: A Meta-Analysis. Journal of Clinical Medicine 11:3, pages 624.
Crossref
Crossref
Chiara Montemitro, Alexandra Angebrandt, Tzu-Yun Wang, Mauro Pettorruso & Osama A. Abulseoud. (2021) Mechanistic insights into the efficacy of memantine in treating certain drug addictions. Progress in Neuro-Psychopharmacology and Biological Psychiatry 111, pages 110409.
Crossref
Crossref
Falk W Lohoff. (2020) Pharmacotherapies and personalized medicine for alcohol use disorder: a review. Pharmacogenomics 21:15, pages 1117-1138.
Crossref
Crossref
Sylvie Blairy & Emmanuel Pinto. 2020. L'alcool en questions. L'alcool en questions
127
137
.
Stefan Gutwinski & Andreas Heinz. 2020. Psychoneurowissenschaften. Psychoneurowissenschaften
255
273
.
Philippe Pfeifer & Christoph Fehr. (2019) Efficacy of Varenicline in Patients With Severe Alcohol Dependence. Journal of Clinical Psychopharmacology 39:4, pages 398-402.
Crossref
Crossref
John C. Umhau. (2019) Conquering the Craving. Journal of Christian Nursing 36:3, pages 148-156.
Crossref
Crossref
Thitiporn Supasitthumrong, Blanca M. Bolea‐Alamanac, Selim Asmer, Vincent L. Woo, Petal S. Abdool & Simon J.C. Davies. (2019) Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report. British Journal of Clinical Pharmacology 85:4, pages 690-703.
Crossref
Crossref
Eduardo Costa Pinto, Chengdong Xu, Lucio Mendes Cabral, Daniel W. Armstrong & Valéria Pereira de Sousa. (2018) Sensitive detection of topiramate degradation products by high‐performance liquid chromatography/electrospray ionization mass spectrometry using ion‐pairing reagents and polarity switching. Rapid Communications in Mass Spectrometry 33:1, pages 116-124.
Crossref
Crossref
Chidera C. Chukwueke & Bernard Le Foll. 2019. Psychiatric Disorders. Psychiatric Disorders
195
219
.
Yan Zhou & Mary Jeanne Kreek. (2018) Involvement of Activated Brain Stress Responsive Systems in Excessive and “Relapse” Alcohol Drinking in Rodent Models: Implications for Therapeutics. Journal of Pharmacology and Experimental Therapeutics 366:1, pages 9-20.
Crossref
Crossref
SY Issa, EM Hafez, AS El-Banna, SM Abdel Rahman, MK AlMazroua & MA El-Hamd. (2017) Baclofen systemic toxicity: Experimental histopathological and biochemical study. Human & Experimental Toxicology 37:4, pages 431-441.
Crossref
Crossref
José Benítez, David García, Nicol Romero, Arlette González, José Martínez-Oyanedel, Maximiliano Figueroa, Mónica Salas, Vasthi López, Peter R. Dodd, Gerhard Schenk, Nelson Carvajal & Elena Uribe. (2018) Metabolic strategies for the degradation of the neuromodulator agmatine in mammals. Metabolism 81, pages 35-44.
Crossref
Crossref
Eduardo Costa Pinto, Mariana da Silva Gonçalves, Lucio Mendes Cabral, Daniel W. Armstrong & Valéria Pereira de Sousa. (2018) Development and validation of a stability-indicating HPLC method for topiramate using a mixed-mode column and charged aerosol detector. Journal of Separation Science 41:8, pages 1716-1725.
Crossref
Crossref
Abhishek Ghosh & Siddharth Sarkar. (2018) Current legislation governing the care of individuals with substance use disorders in India: Rationale and implications. Indian Journal of Social Psychiatry 34:3, pages 189.
Crossref
Crossref
Michael T. Bowen & Inga D. Neumann. (2017) Rebalancing the Addicted Brain: Oxytocin Interference with the Neural Substrates of Addiction. Trends in Neurosciences 40:12, pages 691-708.
Crossref
Crossref
David Boels, Caroline Victorri‐Vigneau, Marie Grall‐Bronnec, Ali Touré, Anais Garnier, Alain Turcant & Gaël Le Roux. (2017) Baclofen and Alcohol‐Dependent Patients: A Real Risk of Severe Self‐Poisoning. Basic & Clinical Pharmacology & Toxicology 121:4, pages 353-359.
Crossref
Crossref
Sebastian T. Peters, Michael T. Bowen, Kathrin Bohrer, Iain S. McGregor & Inga D. Neumann. (2017) Oxytocin inhibits ethanol consumption and ethanol-induced dopamine release in the nucleus accumbens. Addiction Biology 22:3, pages 702-711.
Crossref
Crossref
Yan Zhou, Rachel Saylor Crowley, Konrad Ben, Thomas E. Prisinzano & Mary Jeanne Kreek. (2017) Synergistic blockade of alcohol escalation drinking in mice by a combination of novel kappa opioid receptor agonist Mesyl Salvinorin B and naltrexone. Brain Research 1662, pages 75-86.
Crossref
Crossref
E. T. Goh & M. Y. Morgan. (2017) Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore. Alimentary Pharmacology & Therapeutics 45:7, pages 865-882.
Crossref
Crossref
J. Mutschler & M. Soyka. (2016) Medikamentöse rückfallprophylaktische Behandlung der AlkoholabhängigkeitPharmacological prophylactic treatment for relapse of alcohol dependence. Der Nervenarzt 88:3, pages 303-307.
Crossref
Crossref
Karl Mann, Henri-Jean Aubin & Katie Witkiewitz. (2017) Reduced Drinking in Alcohol Dependence Treatment, What Is the Evidence?. European Addiction Research 23:5, pages 219-230.
Crossref
Crossref
N. W. Gilpin & J. L. Weiner. (2017) Neurobiology of comorbid post-traumatic stress disorder and alcohol-use disorder. Genes, Brain and Behavior 16:1, pages 15-43.
Crossref
Crossref
Michael T. Bowen & Inga D. Neumann. 2018. Behavioral Pharmacology of Neuropeptides: Oxytocin. Behavioral Pharmacology of Neuropeptides: Oxytocin
269
287
.
Michael Soyka & Jochen Mutschler. (2016) Treatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine. Progress in Neuro-Psychopharmacology and Biological Psychiatry 70, pages 148-161.
Crossref
Crossref
Olga Geisel, Rainer Hellweg & Christian A. Müller. (2016) Serum levels of brain-derived neurotrophic factor in alcohol-dependent patients receiving high-dose baclofen. Psychiatry Research 240, pages 177-180.
Crossref
Crossref
Irene Lorrai, Paola Maccioni, Gian Luigi Gessa & Giancarlo Colombo. (2016) R(+)-Baclofen, but Not S(−)-Baclofen, Alters Alcohol Self-Administration in Alcohol-Preferring Rats. Frontiers in Psychiatry 7.
Crossref
Crossref
Joyce Besheer, Suzanne Frisbee, Patrick A. Randall, Anel A. Jaramillo & Maria Masciello. (2016) Gabapentin potentiates sensitivity to the interoceptive effects of alcohol and increases alcohol self-administration in rats. Neuropharmacology 101, pages 216-224.
Crossref
Crossref
Nora D. Volkow, George F. Koob & A. Thomas McLellan. (2016) Neurobiologic Advances from the Brain Disease Model of Addiction. New England Journal of Medicine 374:4, pages 363-371.
Crossref
Crossref
Yan Zhou & Francesco Leri. 2016. Neuroscience for Addiction Medicine: From Prevention to Rehabilitation - Constructs and Drugs. Neuroscience for Addiction Medicine: From Prevention to Rehabilitation - Constructs and Drugs
237
251
.
Sarah G. Helton & Falk W. Lohoff. (2015) Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders. Psychiatry Research 230:2, pages 121-129.
Crossref
Crossref
Amy A. Herrold, Angelle M. Sander, Kimberlee V. Wilson, Lauren M. Scimeca, Derin J. Cobia & Hans C. Breiter. (2015) Dual Diagnosis of Traumatic Brain Injury and Alcohol Use Disorder: Characterizing Clinical and Neurobiological Underpinnings. Current Addiction Reports 2:4, pages 273-284.
Crossref
Crossref
D. Dressler, S. Berweck, A. Chatzikalfas, M. Ebke, B. Frank, S. Hesse, M. Huber, J. K. Krauss, K.-H. Mücke, A. Nolte, H.-D. Oelmann, P. W. Schönle, M. Schmutzler, H. Pickenbrock, C. Van der Ven, N. Veelken, M. Vogel, T. Vogt & F. Adib Saberi. (2015) Intrathecal Baclofen therapy in Germany: Proceedings of the IAB—Interdisciplinary Working Group for Movement Disorders Consensus Meeting. Journal of Neural Transmission 122:11, pages 1573-1579.
Crossref
Crossref
Eduardo Costa Pinto, Maressa Danielli Dolzan, Lucio Mendes Cabral, Daniel W. Armstrong & Valéria Pereira de Sousa. (2015) Topiramate: a review of analytical approaches for biological matrices. Biomedical Chromatography 29:10, pages 1461-1472.
Crossref
Crossref
Eduardo Costa Pinto, Maressa Danielli Dolzan, Lucio Mendes Cabral, Daniel W. Armstrong & Valéria Pereira de Sousa. (2015) Topiramate: A Review of Analytical Approaches for the Drug Substance, Its Impurities and Pharmaceutical Formulations. Journal of Chromatographic Science, pages bmv120.
Crossref
Crossref
Christian A. Müller, Olga Geisel, Patricia Pelz, Verena Higl, Josephine Krüger, Anna Stickel, Anne Beck, Klaus-Dieter Wernecke, Rainer Hellweg & Andreas Heinz. (2015) High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial. European Neuropsychopharmacology 25:8, pages 1167-1177.
Crossref
Crossref
Xiangyang Xie, Wen Lin, Chuanfeng Xing, Yanfang Yang, Qiang Chi, Hui Zhang, Ying Li, Zhiping Li, Yang Yang, Zhenbo Yang & Mingyuang Li. (2015) In Vitro and In Vivo Evaluations of PLGA Microspheres Containing Nalmefene. PLOS ONE 10:5, pages e0125953.
Crossref
Crossref
Sylvie Blairy & Emmanuel Pinto. 2015. L’alcool en questions. L’alcool en questions
129
141
.
Alexander M. Ponizovsky, Paola Rosca, Edward Aronovich, Abraham Weizman & Alexander Grinshpoon. (2015) Baclofen as Add-On to Standard Psychosocial Treatment for Alcohol Dependence: a Randomized, Double-Blind, Placebo-Controlled Trial With 1Year Follow-Up. Journal of Substance Abuse Treatment 52, pages 24-30.
Crossref
Crossref
Antonio Mirijello, Cristina D’Angelo, Anna Ferrulli, Gabriele Vassallo, Mariangela Antonelli, Fabio Caputo, Lorenzo Leggio, Antonio Gasbarrini & Giovanni Addolorato. (2015) Identification and Management of Alcohol Withdrawal Syndrome. Drugs 75:4, pages 353-365.
Crossref
Crossref
Jean-Jacques Chavagnat & Diane Lévy-Chavagnat. (2015) Les médicaments du sevrage et de la réduction de la consommation. Actualités Pharmaceutiques 54:543, pages 26-34.
Crossref
Crossref
María Luisa Gutiérrez García. (2015) Alcohol liver disease: A review of current therapeutic approaches to achieve long-term abstinence. World Journal of Gastroenterology 21:28, pages 8516.
Crossref
Crossref
Beth L. Erwin & Rachel M. Slaton. (2014) Varenicline in the Treatment of Alcohol Use Disorders. Annals of Pharmacotherapy 48:11, pages 1445-1455.
Crossref
Crossref
M. Grall-Bronnec & A. Sauvaget. (2014) The use of repetitive transcranial magnetic stimulation for modulating craving and addictive behaviours: A critical literature review of efficacy, technical and methodological considerations. Neuroscience & Biobehavioral Reviews 47, pages 592-613.
Crossref
Crossref
Audrey MorissetteMDMD, Clairélaine Ouellet-PlamondonMDMD & Didier Jutras-AswadMDMD. (2014) Le craving comme symptôme central de la toxicomanie : de ses fondements neurobiologiques à sa pertinence clinique. Santé mentale au Québec 39:2, pages 21-37.
Crossref
Crossref